A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension

NCT00236665 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

531

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Hypertension

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.